Thursday, 13 April, 2023

Detecting major liver diseases at early stage with non-invasive test

<p>To screen for severe liver illnesses, researchers have developed a liquid biopsy test that makes use of two circulating proteins. The test was discovered to be extremely accurate, sensitive, and specific for both liver fibrosis and non-alcoholic steato-hepatitis (NASH). For the first time, a non-invasive test will make it possible to stage both diseases without having to perform another invasive liver biopsy.</p>